Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Patent Publication Number 20220378770

US 20220378770 A1
Patent NumberUS 11944612 B2
Application Number17881874
Filled DateAug 5, 2022
Priority DateDec 4, 2015
Publication DateDec 1, 2022
Original AssigneePfizer
Current AssigneeGlobal Blood Therapeutics Inc.
Inventor/ApplicantsJoshua Eli Lehrer-Graiwer
Athiwat Hutchaleelaha
Eleanor L. Ramos
Naveen Bejugam
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.